Services Regarding Patents
In over twenty years of patent law experience, I have developed a sophisticated practice focused on the creation of commercial value, including:
Drafting & prosecuting the U.S and foreign patent applications in technologies including chemistry, metallurgy, mechanical systems, optical systems, telecommunications, business methods, and software;
Due diligence assessments of Intellectual Property portfolios including those in support of the $15B acquisition of Organon Biosciences from Akzo and the $43B merger of Schering-Plough with Merck;
Opinions regarding patentability, freedom-to-operate, infringement, and validity;
Cease-and-Desist letters and dispute resolution;
Patent litigation, including a case brought before the International Trade Commission regarding motorized personal watercraft, a case on hydrocarbon processing, and support of ANDA litigations, including those on CLARINEX®, ZETIA®, TEMODAR®, and NOXAFIL®;
Maintaining competitive intelligence in key areas of interest;
Counseling scientific, commercial, and regulatory clients on patent-related matters;
Addressing legal matters associated with the above, including supply agreements, employment agreements, and other contractual matters;
Intellectual Property portfolio management making determinations to safeguard the most valuable and abandon the less valuable IP assets; and,
Maintenance of budgets for worldwide patent prosecution.
I hold BS and MS degrees in Chemical Engineering and have 25 years of industry experience in pharmaceuticals, hydrocarbon processing, fluoropolymers, avionics, and jet engines.
“KABOOM! Recent Misadventures in the Patent World,” delivered at the 2018 National Meeting of the American Institute of Chemical Engineers, New Orleans, La.
“Aqualung Inferred: Inequitable Conduct in Regeneron Pharmaceuticals Inc. v Merus N.V.” delivered at the 2019 National Meeting of the American Institute of Chemical Engineers, Orlando, Fl.